Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. This "Atrial Fibrillation - Pipeline ...

This week, Bobbi Conner talks with Dr. Rachel Kaplan about managing atrial fibrillation. Dr. Kaplan is an Associate Professor ...

Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Chemokines are a subclass of cytokines, a large family of small secreted proteins that communicate via G ...

HUYABIO International today announced favorable Phase 1 clinical data for HBI-3000, a novel bioinspired investigational drug with promising antiarrhythmic properties, excellent tolerability and a ...

Black patients who have been diagnosed with heart failure are no less likely than white patients to get atrial fibrillation (an irregular heartbeat, or arrhythmia), according to a new study. These ...